Inventor
YEN ROSE
US49 patents
⚠️ This page may combine multiple inventors who share the name “YEN ROSE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RIGEL PHARMACEUTICALS INC
33 patentsUS9982000B2May 29, 2018
Pyrazole compounds and method for making and using the compounds
RIGEL PHARMACEUTICALS INC16 citations92
US9067925B2Jun 30, 2015
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC11 citations92
US10590121B2Mar 17, 2020
Kinase inhibitors and methods for making and using
RIGEL PHARMACEUTICALS INC10 citations84
US10208075B2Feb 19, 2019
Pyrazole compounds and method for making and using the compounds
RIGEL PHARMACEUTICALS INC4 citations84
US10208074B2Feb 19, 2019
Pyrazole compounds and method for making and using the compounds
RIGEL PHARMACEUTICALS INC5 citations84
US10065946B2Sep 4, 2018
Benzazole compounds and methods for making and using the compounds
RIGEL PHARMACEUTICALS INC4 citations84
US9611260B2Apr 4, 2017
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC4 citations84
US9566278B2Feb 14, 2017
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC6 citations84
US9321763B2Apr 26, 2016
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC6 citations84
US9084795B2Jul 21, 2015
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC4 citations84
US8343954B2Jan 1, 2013
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC8 citations84
US11530194B2Dec 20, 2022
Amide compounds and method for making and using
RIGEL PHARMACEUTICALS INC1 citations73
US11492349B2Nov 8, 2022
IRAK inhibitors and method for making and using
RIGEL PHARMACEUTICALS INC1 citations73
US11299486B2Apr 12, 2022
Benzazole compounds and methods for making and using the compounds
RIGEL PHARMACEUTICALS INC1 citations73
US10947216B2Mar 16, 2021
Amide compounds and method for making and using
RIGEL PHARMACEUTICALS INC1 citations73
US10941140B2Mar 9, 2021
IRAK inhibitors and method for making and using
RIGEL PHARMACEUTICALS INC2 citations73
US10774076B2Sep 15, 2020
Benzazole compounds and methods for making and using the compounds
RIGEL PHARMACEUTICALS INC3 citations73
US10479783B2Nov 19, 2019
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC2 citations73
US10414753B2Sep 17, 2019
Amide compounds and method for making and using
RIGEL PHARMACEUTICALS INC1 citations73
US10370367B2Aug 6, 2019
IRAK inhibitors and method for making and using
RIGEL PHARMACEUTICALS INC1 citations73
USRE47396EMay 21, 2019
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC1 citations73
US9920041B2Mar 20, 2018
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC2 citations73
US9682976B2Jun 20, 2017
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC3 citations73
US9169249B2Oct 27, 2015
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC4 citations73
US12043620B2Jul 23, 2024
Benzazole compounds and methods for making and using the compounds
RIGEL PHARMACEUTICALS INC0 citations63
US11524955B2Dec 13, 2022
2,4-diamino-pyrimidine compounds and method for making and using the compounds
RIGEL PHARMACEUTICALS INC0 citations63
US11059814B2Jul 13, 2021
Kinase inhibitors and methods for making and using
RIGEL PHARMACEUTICALS INC1 citations63
US11993594B2May 28, 2024
IRAK inhibitors and method for making and using
RIGEL PHARMACEUTICALS INC0 citations62
US11939317B2Mar 26, 2024
Amide compounds and method for making and using
RIGEL PHARMACEUTICALS INC0 citations62
US11370808B2Jun 28, 2022
Pyrazole compounds and methods for making and using the compounds
RIGEL PHARMACEUTICALS INC0 citations62
US11174251B2Nov 16, 2021
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC0 citations62
US10792282B2Oct 6, 2020
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC0 citations52
US10005777B2Jun 26, 2018
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC0 citations52
THERAVANCE RESPIRATORY CO LLC
8 patentsUS9975875B2May 22, 2018
Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC4 citations84
US9771350B2Sep 26, 2017
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC4 citations84
US9682957B2Jun 20, 2017
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC5 citations84
US9572802B2Feb 21, 2017
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC5 citations84
US10138220B1Nov 27, 2018
Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC1 citations62
US10836744B2Nov 17, 2020
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC0 citations51
US10590107B2Mar 17, 2020
Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC0 citations51
US10358433B2Jul 23, 2019
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC0 citations51